Nivolumab Intravenous and Orphenadrine Extended-Release Tablets
Determining the interaction of Nivolumab Intravenous and Orphenadrine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: nivolumab
Brand name: Opdivo
Synonyms: Nivolumab
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nivolumab Intravenous-Orphenadrine Injection
- Nivolumab Intravenous-Orphenadrine w/A.C.
- Nivolumab Intravenous-Orphenadrine, aspirin, and caffeine
- Nivolumab Intravenous-Orphenate
- Nivolumab Intravenous-Orphengesic
- Nivolumab Intravenous-Orphengesic Forte
- Orphenadrine Extended-Release Tablets-Nizatidine
- Orphenadrine Extended-Release Tablets-Nizatidine Capsules and Tablets
- Orphenadrine Extended-Release Tablets-Nizatidine Oral Solution
- Orphenadrine Extended-Release Tablets-Nizatidine Solution
- Orphenadrine Extended-Release Tablets-Nizoral
- Orphenadrine Extended-Release Tablets-No Doz Maximum Strength